Biblio
2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovations. Blood Adv. 2019;3(23):3945-3950.
Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL. Stem Cell Res. 2018;31:157-160.
. Generation of a human Tropomyosin 1 knockout iPSC line. Stem Cell Res. 2023;71:103161.
. Generation of red blood cells from induced pluripotent stem cells. Curr Opin Hematol. 2024.
. In vivo hematopoietic stem cell modification by mRNA delivery. Science. 2023;381(6656):436-443.
Modeling primitive and definitive erythropoiesis with induced pluripotent stem cells. Blood Adv. 2024.
Pluripotent stem cells reveal erythroid-specific activities of the GATA1 N-terminus. J Clin Invest. 2015.
Synergistic roles of DYRK1A and GATA1 in trisomy 21 megakaryopoiesis. JCI Insight. 2023.
. .